Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Bronchopulmonary dysplasia at 28 days · symptomatic patent ductus arteriosus in preterm infants

Indomethacin showed no clear difference in bronchopulmonary dysplasia at 28 days compared with placebo or control (low certainty).

1 finding from 1 review

Indomethacin for symptomatic patent ductus arteriosus in preterm infants 2021 · Cochrane Headline outcomes only
RR 1.45 [0.6, 3.51]
1 study · 55 participants
Low